Success Of German Cost-Control Law Raises Prospect Of Further Cuts For Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany's 2011 pharmaceutical prescribing report shows that the cost control law (AMNOG) is fulfilling its purpose, prompting insurers to call for even further pressure on the industry to reduce costs.